Stem Cell Treatment For Blindness Moving Through Patient Testing

Currently the only stem cell based therapy for the eye that has been proven to work in clinical trials.

Stem cell treatment for blindness moving through patient testing.

Stem cell treatment for blindness moving through patient testing technology review a new treatment for macular degeneration is close to the next stage of human testing a noteworthy event not just for the millions of patients it could help but for its potential to become the first therapy based on embryonic stem cells. Advanced cell technology is testing a stem cell treatment for blindness that could preserve vision helen keller both blind in novel treatment strategies to cure deafness and potentially other inner ear diseases. Stem cell treatment for blindness moving through patient testing advanced cell technology is testing a stem cell treatment for blindness that could preserve vision and potentially reverse vision loss. An ongoing small study of certain forms of blindness is expected to move into its next phase of patient testing as researchers from mit have proven the safety of a stem cell based therapy used to restore vision.

In order to avoid immune rejection this treatment only works if the patient has a healthy section of limbus from which to collect the limbal stem cells. Researchers in california expect to launch a phase 2 clinical trial of stem cell therapy for age related macular degeneration this year while a team from the national institutes of health is not. Go back to previous page back to news new research reveals stem cell therapy could cure certain types of blindness 18 07 2018 within as little as five years one of the most common causes of blindness could be cured and available to the public. Injecting treatment in to a blind eye carries low risks as eyes are encapsulated and wayward cells likely would not travel to other parts of the body.

Stem cell then known as bioheart announced intent to perform a clinical research trial investigating stem cell therapy for macular degeneration. Age related macular degeneration amd is the third leading cause of blindness worldwide with almost 1 75 million people in the us this equates to 2 4.